Introduction
The developing foetus, in response to changes in the in utero environment develops compensatory strategies to overcome insults that they experience. Such compensations could be adaptive, if they support survival, or disruptive, if they compromise postnatal survival. 'Developmental plasticity', the ability of the developing foetus to change structure ⁄ function in response to physiological cues from the mother, underlies the developmental origin of disease or Barker hypothesis (Barker, 1994) . The increased prevalence of some common diseases may be related to exposure during development to environmental pollutants, lifestyle choices of the mother and medical interventions, all of which can adversely influence developmental trajectory of target tissue differentiation. This review addresses the reproductive and metabolic disruptions resulting from exposure to excess native steroids Keywords: bisphenol A, endocrine disrupting chemicals, foetal programming, infertility, insulin resistance, metabolic programming, methoxychlor, neuroendocrine, ovary 
Summary
The inappropriate programming of developing organ systems by exposure to excess native or environmental steroids, particularly the contamination of our environment and our food sources with synthetic endocrine disrupting chemicals that can interact with steroid receptors, is a major concern. Studies with native steroids have found that in utero exposure of sheep to excess testosterone, an oestrogen precursor, results in low birth weight offspring and leads to an array of adult reproductive ⁄ metabolic deficits manifested as cycle defects, functional hyperandrogenism, neuroendocrine ⁄ ovarian defects, insulin resistance and hypertension. Furthermore, the severity of reproductive dysfunction is amplified by excess postnatal weight gain. The constellation of adult reproductive and metabolic dysfunction in prenatal testosterone-treated sheep is similar to features seen in women with polycystic ovary syndrome. Prenatal dihydrotestosterone treatment failed to result in similar phenotype suggesting that many effects of prenatal testosterone excess are likely facilitated via aromatization to oestradiol. Similarly, exposure to environmental steroid imposters such as bisphenol A (BPA) and methoxychlor (MXC) from days 30 to 90 of gestation had long-term but differential effects. Exposure of sheep to BPA, which resulted in maternal levels of 30-50 ng ⁄ mL BPA, culminated in low birth weight offspring. These female offspring were hypergonadotropic during early postnatal life and characterized by severely dampened preovulatory LH surges. Prenatal MXC-treated females had normal birth weight and manifested delayed but normal amplitude LH surges. Importantly, the effects of BPA were evident at levels, which approximated twice the highest levels found in human maternal circulation of industrialized nations. These findings provide evidence in support of developmental origin of adult reproductive and metabolic diseases and highlight the risk posed by exposure to environmental endocrine disrupting chemicals.
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Developmental programming of reproductive/ metabolic dysfunction with native steroids Steroid hormones play a major role during development in setting the trajectory of developing organ systems. Because, differentiation of organ systems depend upon precise exposure to steroid hormones at specific times during development, exposure to low doses of endocrine disrupting compounds (EDCs) that can signal through steroid receptors during these hormone sensitive, critical periods of development can lead to long-term deleterious effects on the adult organism. It is well established that inappropriate exposure to excess testosterone (T) during foetal life leads to phenotypic virilization and behavioural masculinization in the female offspring (Jost et al., 1973; Gorski, 1986; Wood & Foster, 1998) . The amount as well as the timing of T exposure dictates the degree of masculinization of external genitalia in the female (Wood & Foster, 1998) . Inappropriate perinatal exposure to excess T during early development also disrupts reproductive cyclicity in several species (Abbott et al., 2006) .
For the remainder of the review, focus is on the reproductive and metabolic disruptions resulting from inappropriate developmental exposure of sheep to native steroids or environmental steroid mimics. Sheep are exceptionally well suited for investigating developmental programming of adult disorders. They have long been used as model systems to study foetal physiology (Harding & Bloomfield, 2004) . Their developmental time line (gestation length: 147 days, puberty in female: approximately 28 weeks) is ideally suited for integrative studies that address progression of reproductive ⁄ metabolic disruption from the initial developmental insult to manifestation of adult consequences, especially those that involve detailed hormonal profiling or sequential monitoring of ovarian follicular dynamics. Importantly, they can be studied in natural social settings thus reducing the level of stress. From a reproductive perspective, ovarian differentiation in sheep is similar to humans with full follicular differentiation occurring by birth (Fig. 1A ) . Neuroendocrine aspects of reproductive cyclicity are also similar to human (McNeilly, 1991; Goodman & Inskeep, 2006) .
Comparison of sheep treated with T (aromatizable androgen) from days 30 to 90 of gestation (T30-90 females) with those treated from days 60 to 90 of gestation (T60-90 females) has helped address critical period of programming of reproductive and metabolic disruptions. Comparison of prenatal T, prenatal dihydrotestosterone (non-aromatizable androgen, DHT) and T plus flutamide (an androgen antagonist) treatments has helped address the quality of steroid (androgen or oestrogen) responsible for programming adult dysfunctions (Fig. 1B) . Earlier studies with the Dorset breed of sheep found that T30-90 females showed progressive deterioration of cyclicity culminating in absent cycles during the second breeding season ( Fig. 2A) (Birch et al., 2003) . Studies with other breeds of sheep also found progressive loss of cyclicity (Clarke et al., 1977; Manikkam et al., 2006) , the severity of which differing between breeds. In contrast, majority of the T60-90 females cycled during the second breeding season (Birch et al., 2003; Savabieasfahani et al., 2005) . Comparison of cycle dynamics of T30-90 and DHT30-90 females during the oestrous cycle found that T30-90 females were characterized by increased pre-ovulatory levels of oestradiol, as well as delayed and severely dampened LH surges ( Fig. 2B ) . Detailed characterization of circulating LH dynamics during the follicular phase found that T30-90 and T60-90 females were characterized by excess LH release (Savabieasfahani et al., 2005; Manikkam et al., 2008) .
Studies testing the fertility status of T60-90 females found that 100% of the T60-90 females [T30-90 females are phenotypically virilized and natural mating is not possible (Wood & Foster, 1998) ] were mated by the ram. However, fecundity was reduced with only 40% of those mated becoming pregnant as opposed to the 90% pregnancy rate in the control herd ( Fig. 2C) (Steckler et al., 2007b) . Even more importantly, recent studies found that excess postnatal weight gain amplifies the reproductive Developmental programming of adult function V. Padmanabhan et al. disruptions in T30-90 females (Fig. 3A ) . These findings are supportive of the two-step process (Tang et al., 2008) , the first involving early life epigenetic reprogramming of susceptible organ systems and a later event influencing the severity of the pathologic phenotype (Fig. 3B ).
Neuroendocrine disruptions
At the neuroendocrine level, prenatal T treatment reduces hypothalamic sensitivity to all three major feedback systems involved in the control of cyclic changes in GnRH ⁄ gonadotropin secretion; oestradiol (E) negative feedback (Wood & Foster, 1998; Sarma et al., 2005) , E positive feedback (Wood & Foster, 1998; Sharma et al., 2002; Unsworth et al., 2005) and progesterone negative feedback (Robinson et al., 1999; Veiga-Lopez et al., 2009) (Fig. 4) . Further investigations have pointed to disruptions of E negative feedback being programmed by androgenic action of T, with both, T and DHT and not T + flutamide reducing sensitivity to E (Wood & Foster, 1998; Jackson et al., 2008; Veiga-Lopez et al., 2009 ).
E positive feedback disruptions were found in T30-90 but not DHT30-90 females suggesting that this disruption is likely programmed via oestrogenic actions of prenatal T (Wood & Foster, 1998; Veiga-Lopez et al., 2009) . Studies testing pituitary sensitivity also found that both T30-90 and DHT30-90 females have enhanced sensitivity to GnRH suggesting that this aspect is programmed likely via androgenic actions of T (Manikkam et al., 2008) .
Ovarian disruptions
In addition to reproductive neuroendocrine disruptions, prenatal T treatment resulted in larger ovaries with a multifollicular morphology (Fig. 5A ) (West et al., 2001) . These effects appear not to be facilitated by the androgenic actions of T as prenatal DHT treatment failed to create a multifollicular ovarian phenotype (West et al., 2001; Steckler et al., 2007a 
Severity of reproductive phenotype
Step 1 Figure 4 Neuroendocrine feedback systems involved in the control of GnRH ⁄ LH secretion that are reprogrammed by prenatal T excess. GnRH ⁄ LH release is under the control of negative feedback action of oestradiol (E) which is predominant during the pre-pubertal and anestrus period (feedback 1), stimulatory feedback action of E responsible for generation of the pre-ovulatory LH surge (feedback 2) and negative feedback action of progesterone, operational during the luteal phase (feedback 3) (modified from Foster et al., 2007) .
2009) (Fig. 5B) . Similarly, detailed daily ultrasonographic evaluation found that follicles persist longer in prenatal T-treated female (Manikkam et al., 2006) (Fig. 5C ) and this appears to be programmed by oestrogenic actions of prenatal T (Steckler et al., 2007a) . As such, the multifollicular phenotype of prenatal T females appears to be the consequence of both enhanced follicular recruitment and failure to regress. Immunohistochemical studies found that prenatal T treatment increases androgen receptor expression in the stroma and granulosa cells during foetal life and culminates in increased granulosa cell androgen receptor expression in antral follicles of adult females (Ortega et al., 2009) . Taken together these studies document that excess exposure to T disrupts the ovarian trajectory with some aspects programmed by androgenic and others oestrogenic actions of T.
Metabolic dysfunctions
In addition to the neuroendocrine and ovarian disruptions, prenatal T treatment leads to intrauterine growth restriction (IUGR), low birth weight and postnatal catchup growth (Manikkam et al., 2004) , risk factors for adult well being (Boney et al., 2005; Dulloo, 2008) . Developmental changes in the insulin-like growth factor (IGF) ⁄ IGF binding protein (IGFBP) system in the prenatal T-treated sheep were consistent with changes in growth trajectory with a reduction in IGF bioavailability evident during IUGR and an increase during postnatal catch-up growth (Manikkam et al., 2004; Crespi et al., 2006) . Prenatal T treatment also culminated in insulin resistance ( supportive of increased insulin sensitivity (Nada et al., 2009) . Our unpublished observations also indicate increased visceral adiposity in the prenatal T-treated females. Radiotelemetric studies found that the T30-90 females are also hypertensive (King et al., 2007) . Metabolic disruptions have also been reported in other prenatal T-treated animal models (Abbott et al., 2006; Demissie et al., 2008) .
Male reproduction
In contrast to several studies addressing the impact of prenatal T excess in female sheep, limited information is available addressing the impact of prenatal T excess on male reproduction ⁄ metabolism in sheep. Prenatal T treatment increased ano-genital distance in the male offspring compared to controls (Manikkam et al., 2004) , altered the developmental trajectory of gonadal responsiveness to GnRH in pre-pubertal males (Recabarren et al., 2007) and culminated in reduced sperm count and motility (Recabarren et al., 2008) . Prenatal T treatment also increased the volume of the sexually dimorphic nucleus in the males (Roselli et al., 2007) , a complex of aromataseexpressing neurons, whose size has been correlated with sexual attraction in rams. Exposure to an aromatase inhibitor prenatally (days 50-80 of gestation) has also been correlated with decreased adult mounting behaviour (Roselli et al., 2006) . Information is lacking as to whether prenatal T excess disrupts the metabolic axis in the ovine male.
Translational significance
The reproductive phenotype of T30-90 sheep parallels features seen in women with polycystic ovarian disease (PCOS) ( Table 1) . PCOS is one of the most common reproductive disorder affecting more than 100 million women worldwide with the economic burden exceeding several billion dollars annually in the US. Women with PCOS are characterized by oligo-⁄ anovulation, hyperandrogenism, polycystic ovaries, LH hypersecretion and reduced fecundity with most manifesting insulin resistance (Franks, 1995) . Some view PCOS as a clinical phenotype of the metabolic syndrome (Sam & Dunaif, 2003; Essah & Nestler, 2006) . Because the reproductive and metabolic phenotype of prenatal T-treated sheep recapitulates characteristics of women with PCOS, they provide a valuable cost-effective resource for addressing the mechanisms underlying the etiology of development of PCOS phenotype. The constellation of reduced insulin sensitivity, hypertension and visceral adiposity found in prenatal T treatment suggests that these animals may also be suitable for understanding the developmental origin of the metabolic syndrome phenotype (Mikhail, 2009) .
Developmental programming by endocrine disruption chemicals
The inappropriate exposure to steroids is becoming a major concern in the context of development of adult pathologies. The foetus is exposed to exogenous steroids via failed contraception, use of anabolic steroids or inadvertent exposure to environmental compounds with oestrogenic or anti-androgenic activity. Public concern has been mounting over harmful effects of environmental EDC, which can interfere with hormone signalling by acting as agonists or antagonists (Damstra et al., 2002; Hotchkiss et al., 2008) . Of particular concern is the contamination of our environment and food sources with the synthetic androgenic and oestrogenic EDCs, which have the potential to disrupt normal androgen and oestrogen signalling. This review focuses predominantly on two such EDCs namely, bisphenol-A (BPA) a widely used industrial plasticizer and methoxychlor (MXC), a pesticide. BPA is widely used in the manufacture of epoxy resins and polycarbonate plastics and accounts for most oestrogenic activity in landfill leachates (Ranjit et al., 2010; Vandenberg et al., 2009) . It has been detected in river water and sediments and more recently, in indoor air and dust (Ranjit et al., 2010; Vandenberg et al., 2009) . MXC was used to control pests in agricultural, dairy and domestic settings and found to persist in the environment (National Research Council, 1999) . Both these EDCs have been shown to possess oestrogenic and anti-androgenic properties (Staub et al., 2002; Vandenberg et al., 2009) . Targeting critical periods established by treating with native steroids, our recent studies found that prenatal BPA and MXC treatment had differential effects on the reproductive axis (Savabieasfahani et al., 2006) . Prenatal BPA treatment, like prenatal T treatment, resulted in low birth weight offspring, early hypergonadotropism and severely dampened or absent pre-ovulatory LH surges (Fig. 6A-C) . In contrast, MXC had no effect on somatic growth ( Fig. 6A ) but delayed the onset of LH surges (Fig. 5C ). The levels of BPA achieved in maternal circulation following administration of 5 mg ⁄ kg body weight of BPA (Fig. 6D) were two-to threefold higher than the highest levels observed in the maternal circulation of US women (Fig. 6E ) and other industrialized nations (Schonfelder et al., 2002; Vandenberg et al., 2009) . MXC levels in abdominal fat (Savabieasfahani et al., 2006) were several-fold higher than that found in human population (Botella et al., 2004) . Comparison of reproductive defects in BPA-and MXC-treated females with prenatal T-treated model reveal considerable similarities between prenatal BPA-and T-treated models (Table 2 ). Both groups of animals showed reduced birth weight, LH excess and severely dampened pre-ovulatory LH surges (Savabieasfahani et al., 2006) . Others studies in sheep found administration from days 110 to 115 of gestation of octylphenol, a alkylphenol polyethoxylate used in detergents and pesticides with oestrogenic properties, suppressed FSH levels in both female and male offspring (Sweeney et al., 2000) . Administration of octylphenol starting from day 70 of gestation to birth advanced the time of puberty in female offspring (Wright et al., 2002) . Studies testing the effects of BPA and MXC in male sheep are not available. The only available information testing effects of EDC in male sheep comes from studies testing the effects of octylphenol. Prenatal octylphenol treatment from days 70 of gestation to birth reduced testis weight and sertoli cell number in newborns (Sweeney et al., 2000) but not semen volume ⁄ concentration and motility in adult males (Sweeney et al., 2007) . As opposed to the limited information available in sheep, a large volume of literature already exists relative to impact of BPA on the male offspring using rodent models. These rodent studies provide evidence that prenatal BPA exposure leads to disruptions in the male reproductive system, which include constricted urethra and prostate hyperplasia and cancer (Diamanti-Kandarakis et al., 2009; Talsness et al., 2009) . A recent study found exposure to BPA from gestational day 12 to postnatal day 21 reduced sperm count and motility leading to subfertility in the offspring with effects persisting in F2 and F3 generations (Salian et al., 2009) . Similarly exposure to MXC or vinclozolin during gestation resulted in reduced spermatogenic capacity and increased incidence of male infertility with effects transferred to subsequent generations (Anway et al., 2005) .
Conclusions
Studies discussed in this review centring on sheep as a model system enforce that the organizational programme involved in establishing the adult phenotype is the result of the interplay between genetic susceptibility and developmental insults (Fig. 7) . These findings reinforce the concern that inappropriate exposure to steroid hormones ⁄ steroid mimics pose to the well being of the developing offspring. The pathology programmed in sheep by BPA and MXC provides further support for the deleterious effects of EDCs on developing organ systems. Clearly, an understanding of mechanisms underlying developmental reprogramming following exposure to EDCs is essential for developing interventions to prevent development or reduce severity of pathology in adults. Several recent studies point to restoration of function via methylation by dietary supplements (Pennisi, 2005; Waterland, 2006; Dolinoy et al., 2007; Burdge et al., 2009) , providing hope that dietary interventions may be beneficial in improving human health. Environmental exposures are modifiable risk factors and can be effectively regulated at the personal, behavioural as well as the regulatory policy level. For instance, exposure to BPA through sources such as over consumption of fast food and canned food and overuse of baby bottles, can be addressed through public health education campaigns and by health care providers, including physicians, nurses, social workers and dentists. At the policy level, environmental justice advocates can mobilize efforts to protect poor neighbourhoods from exposures to EDCs.
Vasantha Padmanabhan
I presented data on low birthweight with maternal exposure to 5.0 ng ⁄ kg dose of BPA, and maternal hyperinsulinemia with the 0.5 mg ⁄ kg dose. We did not have the resources and personnel to perform glucose tolerance tests in dams treated with other doses of BPA.
Hyunok Choi (Boston, USA)
What are the potential mechanisms by which maternal fat cells might modify the endocrine disrupter effect during pregnancy? Please supply references if possible. I am confused by human data whereby the effect of xenoestrogens can be modified either by fat storage, or by endogenous oestrogens being modified by vessels.
We have not performed studies on maternal obesity. There are some studies which show storage of BPA in fat. This would enable mobilization during lactation, which could affect postnatal programming and development. In the prenatal testosterone treated animals, we have found many of the signalling pathways are affected in fetal ovaries implicating insulin and histone proteins. Clearly epigenetic alterations are involved. These offspring later develop visceral adiposity. The problem with sheep is that the full genome is not yet available although the Australians are working at it. When this is available, we could perform an epigenetic screen to assess if epigenetic changes occur at the level of ERa, ERb and AR.
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